RFX8
DNA-binding protein RFX8
Also known as: FLJ42986, RFX8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZV50
- Gene
- RFX8
- Ensembl
- ENSG00000196460
- Chromosome
- 2
- Canonical length
- 586 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
586 residues, UniProt reviewed canonical sequence.
>Q6ZV50|RFX8
1 MAEGVPASPS SGEGSRGPHS GVIQWLVDNF CICEECSVPR CLMYEIYVET CGQNTENQVN
61 PATFGKLVRL VFPDLGTRRL GTRGSARYHY DGICIKKSSF FYAQYCYLIG EKRYHSGDAI
121 AFEKSTNYNS IIQQEATCED HSPMKTDPVG SPLSEFRRCP FLEQEQAKKY SCNMMAFLAD
181 EYCNYCRDIL RNVEDLLTSF WKSLQQDTVM LMSLPDVCQL FKCYDVQLYK GIEDVLLHDF
241 LEDVSIQYLK SVQLFSKKFK LWLLNALEGV PALLQISKLK EVTLFVKRLR RKTYLSNMAK
301 TMRMVLKSKR RVSVLKSDLQ AIINQGTLAT SKKALASDRS GADELENNPE MKCLRNLISL
361 LGTSTDLRVF LSCLSSHLQA FVFQTSRSKE EFTKLAASFQ LRWNLLLTAV SKAMTLCHRD
421 SFGSWHLFHL LLLEYMIHIL QSCLEEEEEE EDMGTVKEML PDDPTLGQPD QALFHSLNSS
481 LSQACASPSM EPLGVMPTHM GQGRYPVGVS NMVLRILGFL VDTAMGNKLI QVLLEDETTE
541 SAVKLSLPMG QEALITLKDG QQFVIQISDV PQSSEDIYFR ENNANVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RFX8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 3.5 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 3.5 nTPM
- testis: 1 nTPM
- breast: 0.7 nTPM
- adipose tissue: 0.6 nTPM
- thymus: 0.6 nTPM
- thyroid gland: 0.5 nTPM
Single-cell type
- mesothelial cells: 49 nCPM
- thymocytes: 43 nCPM
- retinal ganglion cells: 39 nCPM
- monocyte progenitors: 34 nCPM
- fibro-adipogenic progenitors: 30 nCPM
- late spermatids: 24 nCPM
Immune cell
- basophil: 0.5 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 1.1 nTPM
- hypothalamus: 0.8 nTPM
- medulla oblongata: 0.8 nTPM
- white matter: 0.7 nTPM
- hippocampal formation: 0.5 nTPM
- midbrain: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.25
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RFX8 as an antibody target. Whether an autoantibody or antibody against RFX8 could matter depends on whether native RFX8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RFX8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RFX8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...